{"name":"Bin Cao","slug":"bin-cao","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"cordyceps sinesis capsule","genericName":"cordyceps sinesis capsule","slug":"cordyceps-sinesis-capsule","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"cordyceps sinesis capsule","genericName":"cordyceps sinesis capsule","slug":"cordyceps-sinesis-capsule","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CLVRlZVplRXVHVTVnWUpxTUNhWVBjMHFqRjlYQnpPbXROQ1pmXzBiXzlraXpzcDNwWGZFUmd3VWZLT05PdlI2N1d4UTlQUVdyV2prZkZmUmpIODNZMEhJ?oc=5","date":"2025-08-07","type":"trial","source":"Nature","summary":"The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial - Nature","headline":"The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized control","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOMFc3aGVpRlJvcE1OcHFlb09EdjdKZlJ4ekExRWdSamNhVndjOVE3b1poazNoSDRTajUxVXJjdndNdEZfV3NZdTVhVWRPTmQwdk4tOTJUWWFLY25YZlR6eXVMU043bFVxQmVfaTB3ZTRMRG8ydmVERlMzdUUyUGdIWFU5S2FWNXBMOWNHVlR3?oc=5","date":"2025-04-01","type":"regulatory","source":"Yicai Global","summary":"China Approves Kerui Pharma's Next-Gen Influenza Drug - Yicai Global","headline":"China Approves Kerui Pharma's Next-Gen Influenza Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9ub1pOVDVfcGZ2NWlWNHZ2ckROdWpLU2xjTnN2V1VYV09JYUFoWFVBMkRlRHU2Nkstb1dmdjlfLWZzeFBkVTlEazQxVkZRQTFmUTBWbUFEd0lQcHNSSkV5LUtR?oc=5","date":"2024-09-19","type":"earnings","source":"ACS Publications","summary":"Breaking the Access to Education Barrier: Enhancing HPLC Learning with Virtual Reality - ACS Publications","headline":"Breaking the Access to Education Barrier: Enhancing HPLC Learning with Virtual Reality","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPcHpkbVpRZUVPZHgzS3dTX0RXckxFWlhuRnJMS19sTTMtc05jZXlSa3dtODZacGhDR2F0aWxDMndlQmVsWlc2VjNRWWVTVmVneUhoS0ViWmpTLU9KUDh2RncyVHROZVhVdkU2VWxaZmdkbWF3ODBDVDhLV0dqQndQeGdoRU1vSzFK?oc=5","date":"2024-07-01","type":"trial","source":"The Lancet","summary":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet","headline":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBiTUhHRDRPSkItS0hsZTFOVDBPamlEcGlJTWJ0dE56ZlBsejN2SFJtR0ZGNFNBM19Rc29URS1sSlV6NlhtZmdtbU9TY3RndmRUNmdaU0VtV09tY25HT1BUcw?oc=5","date":"2024-01-17","type":"pipeline","source":"NEJM","summary":"Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 - NEJM","headline":"Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPZkVJT2hVUmxMVjZWUlZGdkVQeFM2SWQ4bTlYMGFwZEJzOUxZMGh3bzg2cWwtM3dSUk1SSWJCYmxKSFFXbUFWUUJHOHlIMHMzOWtaQTR5dHNfUWJhdHJueldXb0JQRU13Vzl2aENXSjVJLVlELWZBRk9IVWNEc0VBTEJRM1hJQ2l0THdDQVl6ZXNnNDIySF9wWlZhakNNWDhBLUJvVUt5d09iZjY3Vks3QVJWTmFibzJFMkxvY25oaw?oc=5","date":"2006-03-01","type":"pipeline","source":"McKinsey & Company","summary":"Balancing ROIC and growth to build value - McKinsey & Company","headline":"Balancing ROIC and growth to build value - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}